Frontier Medicines logo

Frontier Medicines

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients’ lives.

77 employees · est. 2018 · South San Francisco, United...

VS
VarmX logo

VarmX

VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis.

33 employees · est. 2016 · Leiden, The Netherlands

VarmX is the older company (2018 vs 2016); Frontier Medicines is the larger of the two.

Side-by-Side Comparison

Frontier Medicines VarmX
Founded
2018 2016 older
Headquarters
South San Francisco, United States Leiden, The Netherlands
Employees
77 larger 33
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health and Wellness, Manufacturing
Funding Stage
Series C Acquired
Total Funding
$255.50M $205.30M
Funding Rounds
5 10
Services
Covalent drug discovery, Proteome analysis, AI-driven chemoproteomics, Development of precision pipeline Development of universal bypassing agents, Restoration of blood coagulation, Clinical studies and publications
Target Customers
Medical researchers, Pharmaceutical companies, Oncologists, Biotechnology stakeholders Patients on Factor Xa Direct Oral Anticoagulants, Healthcare professionals, Medical institutions
Taxonomy
Biopharmaceutical, Precision Medicine, Drug Discovery, Chemoproteomics, Covalent Drug Discovery, KRAS G12C, Cancer Therapeutics, Protein Targeting, Small-Molecule Drugs, Computational Biology, Disease-driving Proteins, Targeting Undruggable Proteins, Pharmaceutical Pipeline, Technological Platforms Biotech, Hemostasis, Thrombosis, Therapeutic Proteins, Coagulation Factor X, Factor Xa Inhibitors, VMX-C001, PseudoXa, Emergency Surgery, Bleeding Disorders, Direct Oral Anticoagulants (DOACs), Recombinant Proteins, Pharmaceutical Spin-off, Clinical Trials, Drug Development
Website
frontiermeds.com varmx.com
Frontier Medicines logo

About Frontier Medicines

Frontier Medicines, a pioneering force in the biopharmaceutical industry, is dedicated to innovating treatments that target proteins previously considered "undruggable." With its headquarters spanning across South San Francisco, CA, and Boston, MA, the company leverages advanced technologies in chem...

VarmX logo

About VarmX

VarmX is a promising biotech company from The Netherlands, established in 2016. Focusing on the critical sectors of hemostasis and thrombosis, the company has its roots as a spin-off from the Leiden University Medical Center (LUMC). Its mission to develop therapeutic proteins aims to address bleedin...

We will tell you when either one moves

BounceWatch watches Frontier Medicines and VarmX for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Frontier Medicines and VarmX — by email.

Frequently Asked Questions

Frontier Medicines — Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients’ lives.. VarmX — VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Frontier Medicines has raised $255.50M while VarmX has raised $205.30M.
Frontier Medicines and VarmX operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Frontier Medicines with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Frontier Medicines on 15 Jun 2026, and VarmX on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy